ArticleJournal of Indian Association of Pediatric Surgeons
Outcomes of Silver Nitrate Application in the Treatment of Pilonidal Sinus Disease in Children.
Article in Journal of Indian Association of Pediatric Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to retrospectively evaluate the clinical outcomes, recurrence rates, and safety profile of silver nitrate application in pediatric patients diagnosed with pilonidal sinus disease, with a minimum follow-up of 12 months. Materials and Methods: Pediatric patients diagnosed with pilonidal sinus disease and treated with silver nitrate between January 2024 and January 2025 were retrospectively reviewed. Demographic features, comorbidities, body mass index (BMI), number of sinus openings, treatment duration, number of applications, complications, and recurrence rates were recorded. A maximum of four weekly applications was planned. Absence of discharge or swelling at the end of treatment and sustained symptom-free status during follow-up were considered successful outcomes. This study was approved by the Institutional Ethics Committee (Approval No: 2024-KAEK-39), and informed consent was obtained from patient's guardians. Clinical follow-up was conducted at 1, 3, 6, and 12 months posttreatment. Results: A total of 49 patients were included (20 males, 40.8%; 29 females, 59.2%) with a mean age of 15.5 years (range: 13-17). The average number of sinus openings was 2.04. Complete healing was achieved in 42 patients (85.7%), while seven patients (14.3%) required surgical intervention due to persistent discharge after four applications. The mean number of silver nitrate applications required for complete healing was 3.1. Mean BMI was 22.4, and no significant comorbidities were observed. No acute complications such as infection, bleeding, skin irritation, or seroma were observed, and a monitoring protocol for adverse events was followed. During the 12-month follow-up period, no recurrences were detected. Conclusion: Silver nitrate application represents a safe, effective, minimally invasive, and cost-efficient treatment modality for pilonidal sinus disease in children. The absence of recurrence in the 12-month follow-up suggests that silver nitrate may serve as a reliable first-line conservative management strategy before surgical intervention is considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.